Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 17 items for :

  • "aromatase inhibitor" x
Clear All
Yee-Ming M Cheung Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia
Department of Endocrinology, Austin Health, Melbourne, Australia
Division of Endocrinology, Diabetes and Metabolism, Northwell, Great Neck, New York, USA

Search for other papers by Yee-Ming M Cheung in
Google Scholar
PubMed Close
,
Rudolf Hoermann Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia

Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed Close
,
Karen Van Department of Endocrinology, Austin Health, Melbourne, Australia

Search for other papers by Karen Van in
Google Scholar
PubMed Close
,
Damian Wu Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia

Search for other papers by Damian Wu in
Google Scholar
PubMed Close
,
Jenny Healy Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia

Search for other papers by Jenny Healy in
Google Scholar
PubMed Close
,
Bella Halim Department of Endocrinology, Austin Health, Melbourne, Australia

Search for other papers by Bella Halim in
Google Scholar
PubMed Close
,
Manjri Raval Department of Endocrinology, Austin Health, Melbourne, Australia

Search for other papers by Manjri Raval in
Google Scholar
PubMed Close
,
Maria McGill Department of Radiology, Austin Health, Melbourne, Australia

Search for other papers by Maria McGill in
Google Scholar
PubMed Close
,
Ali Al-Fiadh Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia
Department of Cardiology, Austin Health, Melbourne Australia

Search for other papers by Ali Al-Fiadh in
Google Scholar
PubMed Close
,
Michael Chao Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne, Australia

Search for other papers by Michael Chao in
Google Scholar
PubMed Close
,
Shane White Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne, Australia

Search for other papers by Shane White in
Google Scholar
PubMed Close
,
Belinda Yeo Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne, Australia
Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia

Search for other papers by Belinda Yeo in
Google Scholar
PubMed Close
,
Jeffrey D Zajac Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia
Department of Endocrinology, Austin Health, Melbourne, Australia

Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed Close
, and
Mathis Grossmann Department of Medicine, The University of Melbourne, Austin Health, Melbourne, Australia
Department of Endocrinology, Austin Health, Melbourne, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close

Introduction In postmenopausal women with early oestrogen receptor-positive (ER+) breast cancer, aromatase inhibitors (AIs) are the mainstay of adjuvant therapy ( 1 ). In this population, AI therapy is directed at the oestrogen axis and

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0076
Volume/Issue:
Volume 12: Issue 10
Open access
Xi Wang Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

Search for other papers by Xi Wang in
Google Scholar
PubMed Close
and
Qi Yu Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

Search for other papers by Qi Yu in
Google Scholar
PubMed Close

, and the benefits of current interventions have not been well-established due to the rarity of patients and the heterogeneous nature of the disease. Aromatase inhibitors, which were originally developed for the treatment of oestrogen receptor

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0344
Volume/Issue:
Volume 7: Issue 12
Open access
Martin Zweifel Department of Medical Oncology, University Hospital Bern, Bern, Switzerland

Search for other papers by Martin Zweifel in
Google Scholar
PubMed Close
,
Beat Thürlimann Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Beat Thürlimann in
Google Scholar
PubMed Close
,
Salome Riniker Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Salome Riniker in
Google Scholar
PubMed Close
,
Patrik Weder Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Patrik Weder in
Google Scholar
PubMed Close
,
Roger von Moos Kantonsspital Graubünden, Chur, Switzerland

Search for other papers by Roger von Moos in
Google Scholar
PubMed Close
,
Olivia Pagani Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

Search for other papers by Olivia Pagani in
Google Scholar
PubMed Close
,
Martin Bigler SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Martin Bigler in
Google Scholar
PubMed Close
,
Karin M Rothgiesser SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Karin M Rothgiesser in
Google Scholar
PubMed Close
,
Christiane Pilop SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Christiane Pilop in
Google Scholar
PubMed Close
,
Hanne Hawle SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Hanne Hawle in
Google Scholar
PubMed Close
,
Peter Brauchli SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Peter Brauchli in
Google Scholar
PubMed Close
,
Coya Tapia Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Coya Tapia in
Google Scholar
PubMed Close
,
Wolfgang Schoenfeld CURADIS GmbH, Erlangen, Germany

Search for other papers by Wolfgang Schoenfeld in
Google Scholar
PubMed Close
,
Cristiana Sessa Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

Search for other papers by Cristiana Sessa in
Google Scholar
PubMed Close
, and
for the Swiss Group for Clinical Cancer Research (SAKK)
Search for other papers by for the Swiss Group for Clinical Cancer Research (SAKK) in
Google Scholar
PubMed Close

androgen receptor (AR) modulators (SARMs) rather than testosterone may be used to treat AR-positive BC. CR1447 (4-hydroxytestosterone (4-OHT)) is a steroidal small molecule with two distinct properties, acting as a steroidal aromatase inhibitor (AI) and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0174
Volume/Issue:
Volume 6: Issue 7
Open access
Hyun-Ah Kim Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed Close
,
Jihye Choi Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Jihye Choi in
Google Scholar
PubMed Close
,
Chan Sub Park Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Chan Sub Park in
Google Scholar
PubMed Close
,
Min-Ki Seong Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Min-Ki Seong in
Google Scholar
PubMed Close
,
Sung-Eun Hong Department of Translational Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed Close
,
Jae-Sung Kim Division of Basic Radiation Bioscience, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed Close
,
In-Chul Park Division of Basic Radiation Bioscience, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by In-Chul Park in
Google Scholar
PubMed Close
,
Jin Kyung Lee KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Jin Kyung Lee in
Google Scholar
PubMed Close
,
Woo Chul Noh Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

Search for other papers by Woo Chul Noh in
Google Scholar
PubMed Close
, and
the ASTRRA trial investigators
Search for other papers by the ASTRRA trial investigators in
Google Scholar
PubMed Close

Institute of Radiological and Medical Sciences (KIRAMS) Radiation Biobank (KRB02016-bib2). References 1 Smith IE Dowsett M Yap YS Walsh G Lonning PE Santen RJ Hayes D. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0180
Volume/Issue:
Volume 7: Issue 8
Open access
Willem de Ronde Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands

Search for other papers by Willem de Ronde in
Google Scholar
PubMed Close
and
Diederik L Smit Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands

Search for other papers by Diederik L Smit in
Google Scholar
PubMed Close

training intensity. As stated previously, tamoxifen, clomiphene and hCG are frequently used to speed up recovery of gonadal function after a cycle of anabolic steroids. Tamoxifen or aromatase inhibitors may also be used to prevent or treat gynaecomastia

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-19-0557
Volume/Issue:
Volume 9: Issue 4
Open access
Farzaneh Rohani Pediatric Growth and Development Research Center, Iran University of Medical Sciences, Tehran, Iran
Department of Pediatric Endocrinology and Metabolic Diseases, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Search for other papers by Farzaneh Rohani in
Google Scholar
PubMed Close
,
Mohammad Reza Alai Department of Pediatric Endocrinology and Metabolic Diseases, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Search for other papers by Mohammad Reza Alai in
Google Scholar
PubMed Close
,
Sedighe Moradi Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

Search for other papers by Sedighe Moradi in
Google Scholar
PubMed Close
, and
Davoud Amirkashani Department of Pediatrics Endocrinology and Metabolism, Ali Asghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran

Search for other papers by Davoud Amirkashani in
Google Scholar
PubMed Close

. Journal of Pediatrics 1995 126 545 – 550 . ( https://doi.org/10.1016/S0022-3476(95)70347-0 ) 10.1016/S0022-3476(95)70347-0 3 Hero M Wickman S Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0043
Volume/Issue:
Volume 7: Issue 3
Open access
Masatada Watanabe Laboratory of Tissue Regeneration, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa, Tokyo, Japan

Search for other papers by Masatada Watanabe in
Google Scholar
PubMed Close
,
Shuji Ohno Division of Research for Pharmacy Students Education, Hoshi University, Shinagawa, Tokyo, Japan

Search for other papers by Shuji Ohno in
Google Scholar
PubMed Close
, and
Hiroshi Wachi Laboratory of Tissue Regeneration, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa, Tokyo, Japan

Search for other papers by Hiroshi Wachi in
Google Scholar
PubMed Close

the face of women aged 52–70 years improved their skin thickness (epidermis + dermis) ( 2 ). Oral application of an estrogen-conjugated tablet in postmenopausal women improved skin elasticity, moisture and thickness ( 3 ). Aromatase inhibitors (e

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0099
Volume/Issue:
Volume 6: Issue 2
Open access
Michael Ulm University of Tennessee Health Science Center, Memphis, Tennessee, USA
West Cancer Center, Memphis, Tennessee, USA

Search for other papers by Michael Ulm in
Google Scholar
PubMed Close
,
Arvind V Ramesh White Station High School, Memphis, Tennessee, USA

Search for other papers by Arvind V Ramesh in
Google Scholar
PubMed Close
,
Keely M McNamara Tohoku University, Miyagi, Japan

Search for other papers by Keely M McNamara in
Google Scholar
PubMed Close
,
Suriyan Ponnusamy University of Tennessee Health Science Center, Memphis, Tennessee, USA

Search for other papers by Suriyan Ponnusamy in
Google Scholar
PubMed Close
,
Hironobu Sasano Tohoku University, Miyagi, Japan

Search for other papers by Hironobu Sasano in
Google Scholar
PubMed Close
, and
Ramesh Narayanan University of Tennessee Health Science Center, Memphis, Tennessee, USA
West Cancer Center, Memphis, Tennessee, USA

Search for other papers by Ramesh Narayanan in
Google Scholar
PubMed Close

administered as monthly depot demonstrated a 69% response rate in tamoxifen- resistant breast cancer ( 63 ), although this higher response rate was disputed by other groups ( 64 ). Aromatase inhibitors The second mode of estrogen disruption used in

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0425
Volume/Issue:
Volume 8: Issue 2
Open access
Régis Coutant Department of Pediatric Endocrinology and Diabetology, Reference Center for Rare Pituiatry Diseases, University Hospital of Angers, Angers, France

Search for other papers by Régis Coutant in
Google Scholar
PubMed Close
,
Maithé Tauber Reference Center for the Prader-Willi syndrome and other rare obesities with feeding disorders (PRADORT), Children Hospital, CHU Toulouse, Toulouse, France
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France

Search for other papers by Maithé Tauber in
Google Scholar
PubMed Close
,
Béatrice Demaret GRANDIR - French Growth Disorders Association, Asnières-sur-Seine, France

Search for other papers by Béatrice Demaret in
Google Scholar
PubMed Close
,
Robin Henocque Pfizer France, Paris France

Search for other papers by Robin Henocque in
Google Scholar
PubMed Close
,
Yves Brault Pfizer France, Paris France

Search for other papers by Yves Brault in
Google Scholar
PubMed Close
,
François Montestruc eXYSTAT, Malakoff, France

Search for other papers by François Montestruc in
Google Scholar
PubMed Close
,
Olivier Chassany Health Economics Clinical Trial Unit (URC-ECO), Hospital of Hotel-Dieu, AP-HP, Paris, France
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France

Search for other papers by Olivier Chassany in
Google Scholar
PubMed Close
,
Michel Polak Hôpital Universitaire Necker Enfants Malades, Pediatric Endocrinology, Gynecology and Diabetology, Imagine Institute, INSERM U1163, Cochin Institute, INSERM U1016, Centre de référence des pathologies endocriniennes rares de la croissance et du développement, Université de Paris Cité, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close
, and
the QOLITHOR Study Group
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed Close
the QOLITHOR Study Group

treatment onset (months), median (IQR) 3.2 (1.8–5.0) 3.6 (2.0–8.8) 3.5 (1.5–6.0) 3.4 (1.9–7.1) Concomitant aromatase inhibitors, GnRH analog alternative hormone therapy or other injection treatments, n (%) 10 (13.9%) 10 (8

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0464
Volume/Issue:
Volume 12: Issue 4
Open access
Konstantin Yakimchuk Department of Biosciences and Nutrition Karolinska Institutet, Neo, Huddinge, Sweden

Search for other papers by Konstantin Yakimchuk in
Google Scholar
PubMed Close
,
Chandrashekar Bangalore Revanna Department of Biosciences and Nutrition Karolinska Institutet, Neo, Huddinge, Sweden

Search for other papers by Chandrashekar Bangalore Revanna in
Google Scholar
PubMed Close
,
Dan Huang Department of Biosciences and Nutrition Karolinska Institutet, Neo, Huddinge, Sweden

Search for other papers by Dan Huang in
Google Scholar
PubMed Close
,
Jose Inzunza Department of Biosciences and Nutrition Karolinska Institutet, Neo, Huddinge, Sweden

Search for other papers by Jose Inzunza in
Google Scholar
PubMed Close
, and
Sam Okret Department of Biosciences and Nutrition Karolinska Institutet, Neo, Huddinge, Sweden

Search for other papers by Sam Okret in
Google Scholar
PubMed Close

estrogen synthesis by administrating aromatase inhibitors enhanced lymphoma progression in both female and male mice ( 30 ). Importantly, we have also shown that treatment of mice with selective ESR2 agonists inhibits growth of both grafted murine T cell

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0459
Volume/Issue:
Volume 7: Issue 12
Open access